BERKELEY, Calif., May 3 /PRNewswire-FirstCall/ -- Dynavax Technologies
Corporation (Nasdaq: DVAX) today announced that Dr. Dino Dina, President and
Chief Executive Officer, will present at the 29th Annual Deutsche Bank
Securities Health Care Conference in Baltimore, Maryland on Tuesday, May 4,
2004, at 1:30 p.m. Eastern Daylight Savings Time.
Interested parties may access a live webcast of Dr. Dina's presentation by
visiting the Investors > Information > Webcasts page on Dynavax's website at
http://www.dynanvax.com. It is recommended that listeners log on 15 minutes
early in order to register and download any necessary software. If you are
unable to participate during the live webcast, a recorded replay of the
presentation will be available one hour after the presentation is completed
for two weeks.
About Dynavax
Dynavax Technologies Corporation discovers, develops, and intends to
commercialize innovative products to treat and prevent allergies, infectious
diseases, and chronic inflammatory diseases using versatile, proprietary
approaches that alter immune system responses in highly specific ways. Our
clinical development programs are based on immunostimulatory sequences, or
ISS, which are short DNA sequences that enhance the ability of the immune
system to fight disease and control chronic inflammation.
SOURCE Dynavx Technologies Corporation
 back to top
Related links:
http://www.dynavax.com
CONTACT:
Dino Dina, M.D., President and Chief
Executive Officer of Dynavax Technologies Corporation,
+1-510-848-5100
|
